Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-24-000128

Chief Scientific Officer sold 52,115 shares at an average $16.79 ($875,042)

  • Chief Scientific Officer acquired 52,115 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Jewell Christopher M Chief Scientific Officer 2024-11-14 Option exercise +36,050 $3.23 $116,442 61,990 D
Jewell Christopher M Chief Scientific Officer 2024-11-14 Sale −18,550 $16.34 $303,126 43,440 D
Jewell Christopher M Chief Scientific Officer 2024-11-14 Sale −17,500 $17.02 $297,824 25,940 D
Jewell Christopher M Chief Scientific Officer 2024-11-15 Option exercise +16,065 $3.23 $51,890 42,005 D
Jewell Christopher M Chief Scientific Officer 2024-11-15 Sale −16,065 $17.06 $274,093 25,940 D
Derivatives
Jewell Christopher M Chief Scientific Officer 2024-11-14 Option exercise · Stock Option (Right to Buy) −36,050 106,497 D
Jewell Christopher M Chief Scientific Officer 2024-11-15 Option exercise · Stock Option (Right to Buy) −16,065 90,432 D
Open-market sales · 52,115 sh · avg $16.79 · $875,042
Loading xslF345X05/wk-form4_1731975821.xml…